A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit (0787B-092)
NCT00445094 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2017-02-17
Summary
The primary objective of this study is a comparison between MK0787B and standard therapy.
Conditions
Interventions
- DRUG
-
MK0787B, imipenem/cilastatin sodium / Duration of Treatment: 7 Days
- DRUG
-
Comparator: amikacin / Duration of Treatment: 3 Days
- DRUG
-
Comparator: tazocin / Duration of Treatment: 3 Days
- DRUG
-
Comparator: vancomycin / Duration of Treatment: 3 Days
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Monitor · Merck Sharp & Dohme LLC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-11-30
- Primary Completion
- 2007-01-31
- Completion
- 2007-01-31
More Related Trials
-
Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill
NCT04755777 ·Status: COMPLETED
-
Population Pharmacokinetics of Tigecycline in Patients Treated With ECMO
NCT04724798 ·Status: UNKNOWN
-
Diagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia.
NCT05624684 ·Status: COMPLETED
-
Severe Pandemic H1N1 Infection in ICU: Comparative Resource Utilization
NCT01485237 ·Status: COMPLETED
-
Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients
NCT01068990 ·Status: RECRUITING
-
Detection of Pathogen and Antibiotic Resistance Genes by Targeted Next-Generation Sequencing in ICU Patients.
NCT06157372 ·Status: NOT_YET_RECRUITING
-
Procalcitonin Use in Pneumonia Patients in the Critical Care Setting
NCT01788488 ·Status: COMPLETED ·Phase: NA
-
Pneumonia Due to Stenotrophomonas Maltophilia in ICUs
NCT03506191 ·Status: UNKNOWN
-
Hospital-acquired Pneumonia in Intensive Care Unit
NCT03348579 ·Status: COMPLETED
-
Diagnostic Value of sTREM-1 and PCT Level as Well as CPIS Score for Ventilator-Associated Pneumonia Among ICU Sepsis Patients
NCT01406951 ·Status: COMPLETED
-
Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome
NCT03641690 ·Status: COMPLETED
-
PNEUmonia DOSing in Critically Ill Patients (PNEUDOS)
NCT04986254 ·Status: COMPLETED
-
Alterations of the Microbiome During Critical Illness With Short and Long Term Clinical Outcomes
NCT04552834 ·Status: ACTIVE_NOT_RECRUITING
-
Drug Monitoring of Antibiotics in Critical Care Patients
NCT01793012 ·Status: COMPLETED
-
Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients
NCT05115045 ·Status: COMPLETED
-
Validation and Precision Treatment of Inflammatory Subphenotypes in Acute Respiratory Distress Syndrome: A Multicenter Cohort Study
NCT07289711 ·Status: RECRUITING
-
Outcome Factors of Pneumonia Patients in Critical Care Unit
NCT05899192 ·Status: NOT_YET_RECRUITING
-
Anti-pyretic Therapy in Critically Ill Adults
NCT01173367 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Markers to Identify Early Sepsis and Acute Lung Injury
NCT00825357 ·Status: COMPLETED
-
The Gut Microbiome - Source of Sepsis and Novel Target in Intensive Care Units?
NCT06749483 ·Status: RECRUITING
-
Study on ICU Patients With Nosocomial Lower Respiratory Tract Infections
NCT03183921 ·Status: UNKNOWN
-
Pulmonary Microbiota and ARDS Mortality
NCT04133558 ·Status: UNKNOWN
-
Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit
NCT04700202 ·Status: COMPLETED
-
Clinical Characteristics for the Critical Ill Patients With Klebsiella Pneumoniae Infection
NCT04404582 ·Status: COMPLETED
-
A Clinical Cohort Study of Pneumonia in Respiratory Intensive Care Unit
NCT02738645 ·Status: RECRUITING